A Phase 1/1b Study Of Lazertinib As Monotherapy And In Combination With Amivantamab In Advanced Egfr-Mutated Nsclc
JOURNAL OF THORACIC ONCOLOGY(2021)
关键词
lazertinib, amivantamab, EGFR-mutated NSCLC
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF THORACIC ONCOLOGY(2021)